首页> European urology oncology> Combination of Abiraterone Acetate, Prostate Bed Radiotherapy, and Luteinizing Hormone-releasing Hormone Agonists in Biochemically Relapsing Patients After Prostatectomy (CARLHA): A Phase 2 Clinical Trial.

Combination of Abiraterone Acetate, Prostate Bed Radiotherapy, and Luteinizing Hormone-releasing Hormone Agonists in Biochemically Relapsing Patients After Prostatectomy (CARLHA): A Phase 2 Clinical Trial.

导出 LinkOut

翻译打印收藏纠错

第一作者： Loic,Ah-Thiane

第一单位： Department of Radiotherapy, ICO Rene Gauducheau, St-Herblain, France.

作者： Loic,Ah-Thiane ^[1] ; Loic,Campion ^[2] ; Nedjla,Allouache ^[3] ; Emmanuel,Meyer ^[3] ; Pascal,Pommier ^[4] ; Nathalie,Mesgouez-Nebout ^[5] ; Anne-Agathe,Serre ^[4] ; Gilles,Créhange ^[6] ; Valentine,Guimas ^[1] ; Emmanuel,Rio ^[1] ; Paul,Sargos ^[7] ; Sylvain,Ladoire ^[6] ; Céline,Mahier Ait Oukhatar ^[8] ; Stéphane,Supiot ^[9]

作者单位： Department of Radiotherapy, ICO Rene Gauducheau, St-Herblain, France. ^[1] Department of Biostatistics, ICO Rene Gauducheau, St-Herblain, France. ^[2] Department of Radiotherapy, Francois Baclesse Center, Caen, France. ^[3] Department of Radiotherapy, Leon Berard Center, Lyon, France. ^[4] Department of Radiotherapy, ICO Paul Papin, Angers, France. ^[5] Department of Radiotherapy, Georges Francois Leclerc Center, Dijon, France. ^[6] Department of Radiotherapy, Bergonie Institute, Bordeaux, France. ^[7] Groupe des Essais Précoces, Unicancer, Paris, France. ^[8] Department of Radiotherapy, ICO Rene Gauducheau, St-Herblain, France; Inserm UMR1232, CNRS ERL 6001, Nantes University, Nantes, France. Electronic address: Stephane.Supiot@ico.unicancer.fr. ^[9]

关键词 Abiraterone acetate Biochemical recurrence Biomarkers Circulating tumor cells Hormone therapy Prostate bed radiotherapy Prostate cancer Salvage radiotherapy